Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?

Arab Journal of Gastroenterology

Volumn 15, Issue 1, 2014, Pages 12-15

  Almobarak, Ahmed O ^a   Barakat, Salma ^b   Khalifa, Mai H ^a   Elhoweris, Mohamed H ^c   Elhassan, Tayseer M ^d   Ahmed, Mohamed H ^e  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b FEDERAL MINISTRY OF HEALTH   (Sudan)

^c UNIVERSITY OF MEDICAL SCIENCES AND TECHNOLOGY   (Sudan)

^d TOTAL   (France)

^e MILTON KEYNES UNIVERSITY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetes; NAFLD; Obesity; Prevalence; Sudanese

Indexed keywords

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE DURATION; ECHOGRAPHY; FEMALE; GENDER; HUMAN; HYPERTENSION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

DIABETES; NAFLD; OBESITY; PREVALENCE; SUDANESE;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SUDAN;

EID: 84895929627     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2014.01.008     Document Type: Article

References (30)

1. Ahmed M.H., Barakat S., Almobarak A.O. Non alcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?. J Obes 2012, 2012:483135.
2. Muhidin S.O., Magan A.A., Osman K.A., Syed S., Ahmed M.H. The relationship between non alcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. J Obes 2012, 2012:637538.
3. Hamad A.A., Khalil A.A., Connolly V., Ahmed M.H. Relationship between non alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. Arab J Gastroenterol 2012, 13:161-165.
4. Onyekwere C.A., Ogbera A.O., Balogun B.O. Non alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Ann Hepatol 2011, 10:119-124.
5. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
6. Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005, 288:E462-E468.
7. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
8. Dixon J.B., Bhathal P.S., O'Brien P.E. Non alcoholic fatty liver disease: predictors of non alcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
9. Jimba S., Nakagami T., Takahashi M., et al. Prevalence of non alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005, 22:1141-1145.
10. Adams L.A., Lymp J.F., St S.J., et al. The natural history of non alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
11. Adams L.A., Harmsen S., St Sauver J.L., et al. Non alcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010, 105:1567-1573.
12. Schwimmer J.B., Pardee P.E., Lavine J.E., Blumkin A.K., Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric non alcoholic fatty liver disease. Circulation 2008, 118:277-283.
13. Kojima S., Watanabe N., Numata M., Ogawa T., Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12years: analysis of clinical background. J Gastroenterol 2003, 38:954-961.
14. Fan J.G., Zhu J., Li X.J., et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005, 20:1825-1832.
15. Fan J.G., Zhu J., Li X.J., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005, 43:508-514.
16. Akbar D.H., Kawther A.H. Non alcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care 2003, 26:3351-3352.
17. el-Hassan A.Y., Ibrahim E.M., al-Mulhim F.A., Nabhan A.A., Chammas M.Y. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992, 65:774-778.
18. Singh S.P., Nayak S., Swain M., et al. Prevalence of non alcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004, 25:76-79.
19. Park S.H., Jeon W.K., Kim S.H., et al. Prevalence and risk factors of non alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006, 21:138-143.
20. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
21. Liu X., Lazenby A.J., Clements R.H., Jhala N., Abrams G.A. Resolution of non alcoholic steatohepatitis after gastric bypass surgery. Obes Surg 2007, 17:486-492.
22. Luyckx F.H., Lefebvre P.J., Scheen A.J. Non alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000, 26:98-106.
23. Marchesini G., Bugianesi E., Forlani G., et al. Non alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
24. Durward C.M., Hartman T.J., Nickols-Richardson S.M. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes 2012, 2012:460321.
25. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
26. Friis-Liby I., Aldenborg F., Jerlstad P., Rundstrom K., Bjornsson E. High prevalence of metabolic complications in patients with non alcoholic fatty liver disease. Scand J Gastroenterol 2004, 39:864-869.
27. Chen C.H., Huang M.H., Yang J.C., et al. Prevalence and risk factors of non alcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of non alcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006, 40:745-752.
28. Gastaldelli A., Kozakova M., Hojlund K., et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544.
29. Pagano G., Pacini G., Musso G., et al. Non alcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
30. Rocha R., Cotrim H.P., Carvalho F.M., Siqueira A.C., Braga H., Freitas L.A. Body mass index and waist circumference in non alcoholic fatty liver disease. J Hum Nutr Diet 2005, 18:365-370.